Serum IFN-λ1 is abnormally elevated in rheumatoid arthritis patients

Autoimmunity

Volumn 46, Issue 1, 2013, Pages 40-43

  Wu, Qian ^a,b   Yang, Qingrui ^a   Sun, Hongsheng ^a   Li, Ming ^a   Zhang, Yuanchao ^a   Cava, Antonio La ^b  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Ankylosing spondylitis; AS; IFN 1; Interferon 1; NC; Normal controls; RA; Rheumatoid arthritis

Indexed keywords

AUTOANTIBODY; INTERLEUKIN 29; MESSENGER RNA;

ADAPTIVE IMMUNITY; ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN CELL; INNATE IMMUNITY; KNEE; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERLEUKINS; KNEE JOINT; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; STATISTICS, NONPARAMETRIC; YOUNG ADULT;

EID: 84872182662     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.3109/08916934.2012.730587     Document Type: Article

References (19)

1. Choi, S.-I., and E. Brahn. 2010. Rheumatoid arthritis therapy: Advances from bench to bedside. Autoimmunity 43: 478-492.
2. Abe, T., and T. Takeuchi. 2001. Rheumatoid arthritis and tumor necrosis factor a. Autoimmunity 34: 291-303. (Pubitemid 34149822)
3. Kotenko, S. V., G. Gallagher, V. V. Baurin, et al. 2003. IFN-ls mediate antiviral protection through a distinct class II cytokine receptor complex. Nat. Immunol. 4: 69-77. (Pubitemid 36109115)
4. Sheppard, P., W. Kindsvogel,W. Xu, et al. 2003. IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat. Immunol. 4: 63-68. (Pubitemid 36104710)
5. Dumoutier, L., A. Tounsi, T. Michiels, et al. 2004. Role of the interleukin (IL)-28 receptor tyrosine residues for antiviral and antiproliferative activity of IL-29/interferon-l1: Similarities with type I interferon signaling. J. Biol. Chem. 279: 32269-32274. (Pubitemid 39014676)
6. Onoguchi, K., M. Yoneyama, A. Takemura, et al. 2007. Viral infections activate types I and III interferon genes through a common mechanism. J Biol Chem. 282: 7576-7581. (Pubitemid 47093699)
7. Pekarek, V., S. Srinivas, J. Eskdale, et al. 2007. Interferon l-1 (IFN-l1/IL-29) induces ELR-CXC chemokine mRNA in human peripheral blood mononuclear cells, in an IFN-gindependent manner. Genes Immun. 8: 177-180. (Pubitemid 46390918)
8. Maher, S. G., F. Sheikh, A. J. Scarzello, et al. 2008. IFN-A and IFN-l differ in their antiproliferative effects and duration of JAK/STAT signaling activity. Cancer Biol. Ther. 7: 1109-1115.
9. Marcello, T., A. Grakoui, G. Barba-Spaeth, et al. 2006. Interferons a and l inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics. Gastroenterology 131: 1887-1898. (Pubitemid 44958521)
10. Hong, S. H., O. Cho, K. Kim, et al. 2007. Effect of interferonl on replication of hepatitis B virus in human hepatoma cells. Virus Res. 126: 245-249. (Pubitemid 46726717)
11. Hou, W., X. Wang, L. Ye, et al. 2009. l-Interferon inhibits human immunodeficiency virus type 1 infection of macrophages. J. Virol. 83: 3834-3842.
12. Jordan, W. J., J. Eskdale, S. Srinivas, et al. 2007. Human interferon l-1 (IFN-l1/IL-29) modulates the Th1/Th2 response. Genes Immun. 8: 254-261. (Pubitemid 46679436)
13. Srinivas, S., J. Dai, J. Eskdale, et al. 2008. Interferon-l1 (interleukin-29) preferentially down-Regulates interleukin-13 over other T helper type 2 cytokine responses in vitro. Immunology 125: 492-502.
14. Sack, U., R. W. Kinne, T. Marx, et al. 1993. Interleukin-6 in synovial fluid is closely associated with chronic synovitis in rheumatoid arthritis. Rheumatol. Int. 13: 45-51. (Pubitemid 23247813)
15. Arnett, F. C., S. M. Edworthy, D. A. Bloch, D. J. McShane, J. F. Fries, N. S. Cooper, L. A. Healey, S. R. Kaplan, M. H. Liang, H. S. Luthra, T. A. Medsger, D. M. Mitchell, D. H. Neustadt, R. S. Pinals, J. G. Schaller, J. T. Sharp, R. L. Wilder, and G. G. Hunder. 1988. The American Rheumatism Association 1987 revisedcriteria for the classification of rheumatoid arthritis. Arthritis Rheum. 31: 315-324. (Pubitemid 18091653)
16. Horwood, N. 2008. Lymphocyte-Derived cytokines in inflammatory arthritis. Autoimmunity 41: 230-238. (Pubitemid 351454994)
17. Schett, G. 2008. Immune cells and mediators of inflammatory arthritis. Autoimmunity 41: 224-229. (Pubitemid 351454993)
18. Zhou, X., N. Kong, H. Zou, et al. 2011. Therapeutic potential of TGFb-Induced CD4 Foxp3 regulatory T cells in autoimmune diseases. Autoimmunity 44: 43-50.
19. Jordan,W. J., J. Eskdale, M. Boniotto, et al. 2007. Modulation of the human cytokine response by interferon l-1 (IFN-l1/IL-29). Genes Immun. 8: 13-20. (Pubitemid 46164287)